ENDRA Life Sciences Announces Strategy for Early Detection and Management of Metabolic Diseases with GLP-1 Therapies
ENDRA Life Sciences Announces Strategy for Early Detection and Management of Metabolic Diseases with GLP-1 Therapies ENDRA Life Sciences Inc. (NASDAQ: NDRA), a leader in Thermo-Acoustic Enhanced UltraSound (TAEUS®) technology, recently announced a new strategic direction to develop and deploy…
ABEC Launches Breakthrough Single-Use Bioreactor Technology for Cell Therapy
ABEC Launches Breakthrough Single-Use Bioreactor Technology for Cell Therapy ABEC, a global leader in engineered solutions and services for biotech manufacturing, has unveiled its Advanced Therapy Bioreactor (ATB™), a groundbreaking platform designed to revolutionize cell expansion for Advanced Therapy Medicinal…
Cell Therapy for Male Urethral Stricture: BEES-HAUS Trial at Edogawa Hospital, Japan
Cell Therapy for Male Urethral Stricture: BEES-HAUS Trial at Edogawa Hospital, Japan Urethral stricture, a condition that affects men across all age groups but becomes more prevalent after the age of 55, remains a challenging issue despite the availability of…
Exact Sciences Launches Cologuard Plus™ Test for Colorectal Cancer Screening
Exact Sciences Launches Cologuard Plus™ Test for Colorectal Cancer Screening Exact Sciences Corp. (Nasdaq: EXAS), a leader in cancer screening and diagnostic tests, has announced the launch of Cologuard Plus™, a groundbreaking noninvasive colorectal cancer (CRC) screening test. The Cologuard…
Enigma Biomedical Partners to Use 4R PET Imaging Biomarkers in CTE Research
Enigma Biomedical Partners to Use 4R PET Imaging Biomarkers in CTE Research Enigma Biomedical USA, Inc. (EB USA) has announced an exciting new collaboration with the Boston University Chronic Traumatic Encephalopathy (CTE) Center and the Concussion Legacy Foundation. This partnership…
Sphere Bio Launches Cyto-Cellect IgG Kappa and Viability Assay Kit for Single-Cell Selection
Sphere Bio Launches Cyto-Cellect IgG Kappa and Viability Assay Kit for Single-Cell Selection Sphere Bio, a leader in picodroplet-based microfluidics solutions for functional single-cell analysis and isolation, has unveiled the Cyto-Cellect® Human IgG Kappa and Viability Assay Kit. This is…
Convatec Partners with Leading Wound, Ostomy, and Continence Nursing Organization
Convatec Partners with Leading Wound, Ostomy, and Continence Nursing Organization Convatec, a global leader in medical products and technologies focused on managing chronic conditions, has announced an exciting new collaboration with the Wound, Ostomy, and Continence Nurses Society™ (WOCN®), the…
SBC Medical Group Reports Q4 and Full Year 2024 Financial Results
SBC Medical Group Reports Q4 and Full Year 2024 Financial Results SBC Medical Group Holdings Incorporated (NASDAQ: SBC), a global leader in aesthetic practice management services and products, has announced its financial results for the fourth quarter and full year…
GE HealthCare Acquires Nihon Medi-Physics, Leading Radiopharmaceutical Company in Japan
GE HealthCare Acquires Nihon Medi-Physics, Leading Radiopharmaceutical Company in Japan GE HealthCare Technologies Inc. (Nasdaq: GEHC) has successfully completed its acquisition of the remaining 50% stake in Nihon Medi-Physics Co., Ltd (NMP) from Sumitomo Chemical, thereby securing full ownership of…
Novotech Secures New Investment from GIC, Temasek, and TPG to Boost Global Growth
Novotech Secures New Investment from GIC, Temasek, and TPG to Boost Global Growth Novotech, a leading full-service biotech clinical research organization (CRO), announced today that affiliates of GIC and Temasek have entered into binding agreements to acquire a significant stake…
ACC 2025: Sensydia CPS™ Accurately Assesses Mean Pulmonary Artery Pressure Non-Invasively
ACC 2025: Sensydia CPS™ Accurately Assesses Mean Pulmonary Artery Pressure Non-Invasively Sensydia, a clinical-stage company focused on non-invasive cardiac assessments, recently showcased promising clinical findings from a study on its AI-powered Cardiac Performance System (CPS™) at the American College of…
Colorectal Cancer Screening Market to Hit $46.1B by 2029 – ResearchAndMarkets.com
Colorectal Cancer Screening and Diagnostics Market Report Summary Market Overview The “Colorectal Cancer Screening and Diagnostics Market” report provides an in-depth analysis of the colorectal cancer screening and diagnostic testing industry. This comprehensive study includes a market snapshot, company profiles…